Zyla Life Sciences Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 15 rows in 2017. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2017-06-08: Reporting owner CARLIN BARBARA; Form 4; Security Stock Option (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2017-06-08: Reporting owner VARKI PAUL; Form 4; Security Stock Option (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2017-06-08: Reporting owner Shea Patrick M; Form 4; Security Stock Option (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2017-06-08: Reporting owner Dayno Jeffrey M.; Form 4; Security Stock Option (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2017-06-08 | CARLIN BARBARA Officer (Chief Accounting Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +30,000 30,000 owned after | $2.38 exercise price | 2017-06-12 | |
| 2017-06-08 | VARKI PAUL Officer (SVP, GC & Chief Compliance Off) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +50,000 50,000 owned after | $2.38 exercise price | 2017-06-12 | |
| 2017-06-08 | Shea Patrick M Officer (Chief Commercial Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +80,000 80,000 owned after | $2.38 exercise price | 2017-06-12 | |
| 2017-06-08 | Dayno Jeffrey M. Officer (Chief Medical Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +80,000 80,000 owned after | $2.38 exercise price | 2017-06-12 | |
| 2017-06-08 | Strobeck Mark Officer (Chief Operating Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +100,000 100,000 owned after | $2.38 exercise price | 2017-06-12 | |
| 2017-06-08 | Musial Stan Officer (Chief Financial Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +100,000 100,000 owned after | $2.38 exercise price | 2017-06-12 | |
| 2017-06-08 | Radie Robert S Director, Officer (President and CEO) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +150,000 150,000 owned after | $2.38 exercise price | 2017-06-12 | |
| 2017-06-08 | WEAVER GREGORY L Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +58,133 58,133 owned after | $2.38 exercise price | 2017-06-12 | |
| 2017-06-08 | ROCHE ROBERT P JR Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +58,133 58,133 owned after | $2.38 exercise price | 2017-06-12 | |
| 2017-06-08 | OSBORN JOHN E Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +58,133 58,133 owned after | $2.38 exercise price | 2017-06-12 | |
| 2017-06-08 | NICOLAIDES NICHOLAS C Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +58,133 58,133 owned after | $2.38 exercise price | 2017-06-12 | |
| 2017-06-08 | Walbert Timothy P Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +58,133 58,133 owned after | $2.38 exercise price | 2017-06-12 | |
| 2017-05-01 | Hochberg Elaine Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +51,817 51,817 owned after | $3.67 exercise price | 2017-05-02 | |
| 2017-05-01 | Smiley Andrea Heslin Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +51,817 51,817 owned after | $3.67 exercise price | 2017-05-02 | |
| 2017-01-03 | ROCHE ROBERT P JR Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +26,282 26,282 owned after | $7.96 exercise price | 2017-01-04 |